These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9256905)

  • 21. Taxane-based therapy for breast cancer: combination or sequential therapy?
    Sparano JA; Rajdev L
    Cancer Invest; 2000; 18(5):498-500. PubMed ID: 10834036
    [No Abstract]   [Full Text] [Related]  

  • 22. Taxoids: new weapons against cancer.
    Nicolaou KC; Guy RK; Potier P
    Sci Am; 1996 Jun; 274(6):94-8. PubMed ID: 8643952
    [No Abstract]   [Full Text] [Related]  

  • 23. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
    Belani CP
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Docetaxel-induced subungual hemorrhage.
    Vanhooteghem O; André J; Vindevoghel A; Vandenbossche L; Vandeveire A; Song M
    Dermatology; 1997; 194(4):419-20. PubMed ID: 9252781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to dexamethasone in patients with fluid retention after docetaxel.
    Chan S; Winterbottom L; Gardner S
    Lancet; 1996 May; 347(9013):1486-7. PubMed ID: 8676655
    [No Abstract]   [Full Text] [Related]  

  • 26. Meeting highlights 38th annual meeting of the American Society of Clinical Oncology. Advances in adjuvant chemotherapy for management of breast cancer: the emerging role of docetaxel.
    Street JC; Taguchi T
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1689-92. PubMed ID: 12355960
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversible life-threatening encephalopathy in the absence of hepatic failure following conventional doses of docetaxel.
    Guglani S; Farrugia D; Elsdon M; Parmar M; Owen JR
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):160-1. PubMed ID: 12801056
    [No Abstract]   [Full Text] [Related]  

  • 28. Docetaxel: today's results and tomorrow's promises.
    Hortobagyi GN
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):11-4. PubMed ID: 9364535
    [No Abstract]   [Full Text] [Related]  

  • 29. An overview of phase II studies of docetaxel in patients with metastatic breast cancer.
    Eisenhauer EA; Trudeau M
    Eur J Cancer; 1995; 31A Suppl 4():S11-3. PubMed ID: 7577098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rapid and systematic review of the effectiveness and cost-effectiveness of the taxanes used in the treatment of advanced breast and ovarian cancer.
    Lister-Sharp D; McDonagh MS; Khan KS; Kleijnen J
    Health Technol Assess; 2000; 4(17):1-113. PubMed ID: 11074389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docetaxel as neoadjuvant chemotherapy in patients with stage III breast cancer.
    Gradishar WJ
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):15-8. PubMed ID: 9364536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The taxoids: paclitaxel and docetaxel.
    Gelmon K
    Lancet; 1994 Nov; 344(8932):1267-72. PubMed ID: 7967989
    [No Abstract]   [Full Text] [Related]  

  • 33. Taxanes in the treatment of breast cancer: a prodigy comes of age.
    Miller KD; Sledge GW
    Cancer Invest; 1999; 17(2):121-36. PubMed ID: 10071597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Low-dose weekly administration of docetaxel for metastatic breast cancer].
    Kimijima I; Watanabe T; Sagara H; Ohtake T; Tsuchiya A; Abe R
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):995-9. PubMed ID: 10396330
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of efficacy and toxicity of docetaxel (Taxotere) in patients with advanced mammary gland cancer].
    Pawlicki M; Rolski J; Zemełka T; Utych G; Wiczyńska B; Rysz B
    Przegl Lek; 2001; 58(2):59-60. PubMed ID: 11475843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of docetaxel-resistant breast cancer responsive to paclitaxel therapy].
    Oura S; Tanino H; Yoshimasu T; Sakurai T; Nakamura T; Kokawa Y; Matsuyama K; Naito Y
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):511-4. PubMed ID: 11329786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fulminant hepatocellular necrosis following administration of docetaxel].
    Tomassini E; Muhizi J; al Raheb K; Steinbach G; Bemer M; Platini C
    Presse Med; 2001 Apr; 30(13):634. PubMed ID: 11346902
    [No Abstract]   [Full Text] [Related]  

  • 38. [A case of recurrent breast cancer successfully treated with docetaxel].
    Nakagawa T; Kudo T; Onuki M; Seto T; Kamata S; Kiyosawa Y; Ogawa J
    Gan To Kagaku Ryoho; 2001 Mar; 28(3):383-5. PubMed ID: 11265409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel and docetaxel in the treatment of breast cancer.
    Saloustros E; Mavroudis D; Georgoulias V
    Expert Opin Pharmacother; 2008 Oct; 9(15):2603-16. PubMed ID: 18803448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel and docetaxel in breast and ovarian cancer.
    Drug Ther Bull; 1997 Jun; 35(6):43-6. PubMed ID: 9282422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.